Advertisement
Research Article Free access | 10.1172/JCI110358
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Cell Biology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Department of Nephrology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Pennington, J. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Cell Biology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Department of Nephrology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Hickey, W. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Cell Biology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Department of Nephrology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Blackwood, L. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115
Department of Cell Biology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Department of Nephrology, Children's Hospital Medical Center, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Arnaut, M. in: JCI | PubMed | Google Scholar
Published November 1, 1981 - More info
Chronic respiratory infection with Pseudomonas aeruginosa is a leading clinical problem among patients with cystic fibrosis. Because antimicrobial agents are usually ineffective in eradicating these infections, additional therapeutic or prophylactic measures should be considered. In this study, an experimental guinea pig model of chronic Pseudomonas aeruginosa bronchopneumonia was utilized to determine whether active immunization with lipopolysaccharide (LPS) P. aeruginosa antigen may favorably influence the course of this infection. Experimental pneumonia was established by tracheobronchial instillation of suspensions of microscopic agar beads, which were impregnated with viable P. aeruginosa. After 4 wk of infection, the geometric mean (reciprocal) passive hemagglutinating Pseudomonas antibody titer was 185±1.3, and lungs contained 16.8±4 × 103 colony-forming units Pseudomonas/ml of lung homogenate. Pseudomonas immunization, given prior to a 4-wk infection, resulted in significantly higher passive hemagglutinating titers (474±1.4; P < 0.05), lower numbers of viable Pseudomonas in lung tissues (2.4±0.6 × 103; P < 0.01), and reduced histopathology in lungs. In contrast, providing Pseudomonas immunization to animals 2 wk after pulmonary infection was established, offered no apparent benefit. Likewise, no protection was afforded by prophylactic immunization with a non-Pseudomonas LPS antigen (Escherichia coli J5 vaccine). Using a Raji cell assay, modified to detect circulating immune complexes in vaccinated and infected guinea pig sera, there was no evidence that active immunization increased the frequency of circulating immune complexes in infected guinea pigs.It is concluded that prophylactic immunization with Pseudomonas LPS antigen may confer protection from subsequent Pseudomonas bronchopneumonia, but that immunization during established infection is not beneficial.
Images.